Latest biopharmaceutical Stories
CHAPEL HILL, N.C., Feb. 13, 2015 /PRNewswire/ -- Recent biopharmaceutical product launches have produced both noteworthy failures and successes.
Texas-based CMO, VGXI engages in mutually beneficial partnership to provide the industry with a unified solution for plasmid manufacturing from preclinical through commercial supply.
MONROVIA, Calif., Feb. 12, 2015 /PRNewswire/ -- Xencor, Inc.
LONDON, February 11, 2015 /PRNewswire/ -- Report Details Biosimilar therapeutic antibodies - see why originator companies should now fear those competitors,
-Extended Follow-Up Shows 4/14 Patients Treated with a Single SC Dose of 2 mg/kg of RG-101 are Target Not Detected at Day 85 - LA JOLLA, Calif., Feb.
DALLAS and NEW YORK, Feb. 6, 2015 /PRNewswire/ -- PlasmaTech Biopharmaceuticals, Inc.
BCC Research (http://www.bccresearch.com) reveals in its new report on biologic therapeutic drugs; the biologics or biopharmaceutical therapeutic
EWING, N.J., Feb. 2, 2015 /PRNewswire/ -- Celator Pharmaceuticals, Inc.
EDISON, N.J., Feb. 2, 2015 /PRNewswire/ -- ContraVir Pharmaceuticals, Inc.
- an ornament or knob in the shape of a flower
- In architecture, a floral ornament; specifically, the large conventional flower usually placed in the center of the abacus of a Corinthian capital or classic ceiling-caisson; also, the floreated termination of a Gothic finial.